Originally published by our sister publication Pharmacy Practice News
By David Bronstein
PHOENIX—Given enough cause, the Drug Enforcement Administration (DEA) will inspect pharmacies that fail to recognize and address suspicious prescriptions for controlled substances (CS). Dispensers that ignore these “red flag” prescriptions subject their licenses, their pharmacies and themselves to DEA and state enforcement action, a CS compliance expert noted during APhA2023.